![Karen Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karen Smith
Director/Board Member at
SKYE BIOSCIENCE, INC.
Net worth: 220 557 $ as of 30/06/2026
Profile
Dr. Karen L. Smith is a Chief Medical Officer at Emergent BioSolutions, Inc., an Independent Director at Antares Pharma, Inc., an Independent Director at Sangamo Therapeutics, Inc. and an Independent Director at Acceleron Pharma, Inc. She is on the Board of Directors at Antares Pharma, Inc., Sangamo Therapeutics, Inc. and Acceleron Pharma, Inc. Dr. Smith was previously employed as a President & Chief Executive Officer by Medeor Therapeutics, Inc., a Chief Executive Officer by Eliminate Cancer, Inc., a Director & Vice President by Celator Pharmaceuticals, Inc., a Non-Executive Director by Forward Pharma A/S, a Chief Medical Officer & EVP-Research & Development by Jazz Pharmaceuticals Plc, a SVP-Global Medical Affairs & Head-Dermatology by Allergan, Inc., a Head-External Medical Relations by AstraZeneca LP, a Head-US Clinical Operations by Bristol Myers Squibb Co., and a Chief Executive Officer by Boron Molecular Ltd. She also served on the board at Sucampo Pharmaceuticals, Inc. She received her undergraduate degree from Curtin University of Technology, a graduate degree from the University of Salford, an MBA from the University of New England (Australia), a doctorate degree from the University of Warwick and a doctorate degree from The University of Western Australia.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 12/04/2025 | 12,672 ( 0.01% ) | 215 044 $ | 30/06/2026 | |
| 12/06/2025 | 102,100 ( 0.02% ) | 5 513 $ | 30/06/2026 | |
| 31/03/2026 | 0 ( -.--% ) | - $ | 30/06/2026 | |
| 24/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Karen Smith active positions
| Companies | Position | Start |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Director/Board Member | 28/06/2018 |
| EMYRIA LIMITED | Director/Board Member | 29/11/2021 |
| SKYE BIOSCIENCE, INC. | Director/Board Member | 02/07/2024 |
| CONTEXT THERAPEUTICS INC. | Director/Board Member | 04/09/2024 |
Former positions of Karen Smith
| Companies | Position | End |
|---|---|---|
| TOUE BIOPAR | Director/Board Member | 01/10/2023 |
Novosteo, Inc.
 Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug to reduce complications from a broken bone due to a fall | Chief Tech/Sci/R&D Officer | 01/09/2023 |
| QUINCE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/09/2023 |
| ANTARES PHARMA, INC. | Director/Board Member | 24/05/2022 |
| EMERGENT BIOSOLUTIONS INC. | Chief Tech/Sci/R&D Officer | 01/12/2021 |
Training of Karen Smith
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
79
1st degree connections
31
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 31 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops parenteral pharmaceutical products | Health Technology |
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Celator Pharmaceuticals, Inc.
 Celator Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat acute myeloid leukemia and AML with myelodysplasia in children & adults | Health Technology |
University of Salford
 University of Salford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boron Molecular Ltd.
 Boron Molecular Ltd. Chemicals: Major DiversifiedProcess Industries Produces and distributes chemicals and compounds to the pharmaceutical and biotechnology industries | Process Industries |
Emergent BioSolutions, Inc.
 Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Sucampo Pharmaceuticals LLC
 Sucampo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures prostone based pharmaceuticals products | Health Technology |
University of Warwick
 University of Warwick Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Western Australia
 The University of Western Australia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of New England (Australia)
 University of New England (Australia) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Forward Pharma A/S
 Forward Pharma A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures proprietary formulations for inflammatory and neurological indications | Health Technology |
Humanetics Corp.
 Humanetics Corp. Pharmaceuticals: MajorHealth Technology Develops and commercializes oncology, inflammatory diseases & biodefense drugs | Health Technology |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
Jazz Pharmaceuticals Plc
 Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
Aurinia Pharmaceuticals, Inc.
 Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Quince Therapeutics, Inc.
 Quince Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders and Alzheimer’s diseases | Health Technology |
Skye Bioscience, Inc.
 Skye Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets cannabinoid derivatives to treat ophthalmic disorders | Health Technology |
Talaris Therapeutics, Inc.
 Talaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Medeor Therapeutics, Inc.
 Medeor Therapeutics, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies for organ transplant recipients | Health Technology |
Curtin University of Technology
 Curtin University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emyria Ltd.
 Emyria Ltd. Packaged SoftwareTechnology Services Develops patient-centric care model technology | Technology Services |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug to reduce complications from a broken bone due to a fall | Health Technology |
Eliminate Cancer, Inc. | |
Context Therapeutics, Inc.
 Context Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops treatment options for women living with hormone-dependent cancer | Health Technology |
Mariana Oncology, Inc.
 Mariana Oncology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company pioneering a new era of radiopharmaceutical innovation to treat people with cancer | Health Technology |
Capstan Therapeutics, Inc.
 Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops targeted in vivo RNA technologies | Commercial Services |
- Stock Market
- Insiders
- Karen Smith
